Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-21-000509
Filing Date
2021-01-28
Accepted
2021-01-28 16:15:33
Documents
2
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-K/A tmb-20200930x10ka.htm 10-K/A 550847
2 EX-31.1 tmb-20200930xex31d1.htm EX-31.1 6248
  Complete submission text file 0001558370-21-000509.txt   558201
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-37759 | Film No.: 21565127
SIC: 2836 Biological Products, (No Diagnostic Substances)